At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Feb 22, 2026 at 19:00 ET
CEO Marianne De Backer and EVP Vanina de Verneuil sold significant shares in Vir Biotechnology, totaling $175K in proceeds over two days, while also receiving large option awards. The cluster reflects a mix of profit-taking and long-term incentive alignment, with no immediate buying signal.
- CEO Marianne De Backer sold 19,039 shares for $141,894 on 2026-02-23
- EVP Vanina de Verneuil sold 4,445 shares for $33,128 on 2026-02-23
- Both executives received substantial option awards on 2026-02-22 (CEO: 285,000 shares, EVP: 55,000 shares) at $0 exercise price
- All sales occurred at market price (~$7.45), indicating normal post-grant selling or diversification
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access